Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients

被引:3
作者
Bedussi, Francesca [1 ,2 ]
Valcamonico, Francesca [1 ]
Mosca, Alessandra [3 ]
Sigala, Sandra [2 ]
Ferrari, Laura [1 ]
Terrone, Carlo [4 ]
Dalla Volta, Alberto [1 ]
Marchioro, Giansilvio [4 ]
Ferrari, Vittorio [1 ]
Alabiso, Oscar [3 ]
Memo, Maurizio [2 ]
Berruti, Alfredo [1 ]
机构
[1] Univ Brescia, Dept Surg Radiol & Publ Hlth, Spedali Civili Brescia, Oncol Unit, Brescia, Italy
[2] Univ Brescia, Pharmacol Sect, Dept Mol & Translat Med, Brescia, Italy
[3] Univ Piemonte Orientale, Maggiore della Carita Univ Hosp, Med Oncol, Novara, Italy
[4] Univ Piemonte Orientale, Maggiore della Carita Univ Hosp, Urol, Novara, Italy
关键词
INCREASED SURVIVAL; MITOXANTRONE; PREDNISONE; ABIRATERONE; CHEMOTHERAPY; MECHANISMS;
D O I
10.1007/s12020-015-0827-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:830 / 833
页数:4
相关论文
共 20 条
[1]   Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline [J].
Basch, Ethan ;
Loblaw, D. Andrew ;
Oliver, Thomas K. ;
Carducci, Michael ;
Chen, Ronald C. ;
Frame, James N. ;
Garrels, Kristina ;
Hotte, Sebastien ;
Kattan, Michael W. ;
Raghavan, Derek ;
Saad, Fred ;
Taplin, Mary-Ellen ;
Walker-Dilks, Cindy ;
Williams, James ;
Winquist, Eric ;
Bennett, Charles L. ;
Wootton, Ted ;
Rumble, R. Bryan ;
Dusetzina, Stacie B. ;
Virgo, Katherine S. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (30) :3436-U133
[2]   Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival in the TAX 327 study [J].
Berthold, Dominik R. ;
Pond, Gregory R. ;
Soban, Freidele ;
de Wit, Ronald ;
Eisenberger, Mario ;
Tannock, Ian F. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) :242-245
[3]   Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer [J].
Darshan, Medha S. ;
Loftus, Matthew S. ;
Thadani-Mulero, Maria ;
Levy, Benjamin P. ;
Escuin, Daniel ;
Zhou, Xi Kathy ;
Gjyrezi, Ada ;
Chanel-Vos, Chantal ;
Shen, Ruoqian ;
Tagawa, Scott T. ;
Bander, Neil H. ;
Nanus, David M. ;
Giannakakou, Paraskevi .
CANCER RESEARCH, 2011, 71 (18) :6019-6029
[4]   Abiraterone and Increased Survival in Metastatic Prostate Cancer [J].
De Bono, Johann S. ;
Logothetis, Christopher J. ;
Molina, Arturo ;
Fizazi, Karim ;
North, Scott ;
Chu, Luis ;
Chi, Kim N. ;
Jones, Robert J. ;
Goodman, Oscar B., Jr. ;
Saad, Fred ;
Staffurth, John N. ;
Mainwaring, Paul ;
Harland, Stephen ;
Flaig, Thomas W. ;
Hutson, Thomas E. ;
Cheng, Tina ;
Patterson, Helen ;
Hainsworth, John D. ;
Ryan, Charles J. ;
Sternberg, Cora N. ;
Ellard, Susan L. ;
Flechon, Aude ;
Saleh, Mansoor ;
Scholz, Mark ;
Efstathiou, Eleni ;
Zivi, Andrea ;
Bianchini, Diletta ;
Loriot, Yohann ;
Chieffo, Nicole ;
Thian Kheoh ;
Haqq, Christopher M. ;
Scher, Howard I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (21) :1995-2005
[5]   Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial [J].
de Bono, Johann Sebastian ;
Oudard, Stephane ;
Ozguroglu, Mustafa ;
Hansen, Steinbjorn ;
Machiels, Jean-Pascal ;
Kocak, Ivo ;
Gravis, Gwenaelle ;
Bodrogi, Istvan ;
Mackenzie, Mary J. ;
Shen, Liji ;
Roessner, Martin ;
Gupta, Sunil ;
Sartor, A. Oliver .
LANCET, 2010, 376 (9747) :1147-1154
[6]   Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study [J].
Fizazi, Karim ;
Scher, Howard I. ;
Molina, Arturo ;
Logothetis, Christopher J. ;
Chi, Kim N. ;
Jones, Robert J. ;
Staffurth, John N. ;
North, Scott ;
Vogelzang, Nicholas J. ;
Saad, Fred ;
Mainwaring, Paul ;
Harland, Stephen ;
Goodman, Oscar B., Jr. ;
Sternberg, Cora N. ;
Li, Jin Hui ;
Kheoh, Thian ;
Haqq, Christopher M. ;
de Bono, Johann S. .
LANCET ONCOLOGY, 2012, 13 (10) :983-992
[7]   Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion [J].
Harris, William P. ;
Mostaghel, Elahe A. ;
Nelson, Peter S. ;
Montgomery, Bruce .
NATURE CLINICAL PRACTICE UROLOGY, 2009, 6 (02) :76-85
[8]  
James N.D., 2015, ASCO 2015
[9]   Microtubules as a target for anticancer drugs [J].
Jordan, MA ;
Wilson, L .
NATURE REVIEWS CANCER, 2004, 4 (04) :253-265
[10]   Understanding the Mechanisms of Androgen Deprivation Resistance in Prostate Cancer at the Molecular Level [J].
Karantanos, Theodoros ;
Evans, Christopher P. ;
Tombal, Bertrand ;
Thompson, Timothy C. ;
Montironi, Rodolfo ;
Isaacs, William B. .
EUROPEAN UROLOGY, 2015, 67 (03) :470-479